BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Auris Medical AG 

Aeschenvorstadt 37

Basel    4051  Switzerland
Phone: 41-61-201-13-50 Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Published Analysis Confirms Positive Results From Auris Medical AG's Phase 2b Study With AM-101 In Treatment Of Acute Inner Ear Tinnitus 3/31/2014 9:01:12 AM    More...
Auris Medical AG Announces Enrollment Of First Patient In North American Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 3/10/2014 9:12:37 AM    More...
Auris Medical AG Announces Enrollment Of First Patient In European Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 2/21/2014 8:55:18 AM    More...
Auris Medical AG Reaches Special Protocol Assessment Agreement With FDA for Pivotal Phase III Clinical Trial With AM-101 in Treatment of Acute Peripheral Tinnitus 11/4/2013 9:40:11 AM    More...
Second Phase II Clinical Trial Confirms Safety and Efficacy Trends for Auris Medical AG's AM-101 in Treatment of Acute Peripheral Tinnitus 9/9/2013 9:27:19 AM    More...
Safety Results From Auris Medical AG's Clinical Development of AM-101 Presented at International Conference 5/17/2013 9:25:22 AM    More...
Auris Medical AG Secures $50.6 Million Series C Financing 4/16/2013 6:39:06 AM    More...
Auris Medical AG Completes Enrolment in TACTT1 Study With AM-101 for the Treatment of Acute Peripheral Tinnitus 2/13/2013 2:35:17 PM    More...
Auris Medical AG Reporting Positive Results From Phase IIb Trial With AM-111 for the Treatment of Acute Sensorineural Hearing Loss 11/13/2012 11:34:35 AM    More...
Auris Medical AG Completes Enrollment in First Stage of AM-101 TACTT1 Study 8/10/2012 11:36:58 AM    More...
1234

//-->